Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophreniaGiselli Scaini, Consuelo Walss‐Bass, João Quevedo et al.|European Neuropsychopharmacology|2018Cited by 64